Back to Journal

Cholesterol is one of the most misunderstood molecules in human health. For decades, the conventional narrative has been simple: cholesterol is bad, dietary fat raises it, and lowering it with medication prevents heart disease. But the reality is far more nuanced, and for practitioners working in functional nutrition, understanding that nuance is essential to helping clients effectively.

This article takes a systems-level view of cholesterol — what it actually does in the body, why it becomes elevated, which myths continue to mislead both practitioners and the public, and what evidence-based nutrition interventions can address the root causes rather than simply suppressing a lab number.

Understanding Triglycerides and Cholesterol: What They Actually Do

Before we can talk about what goes wrong with cholesterol metabolism, we need to understand what cholesterol and triglycerides actually are and why the body makes them. These are not waste products or toxins. They are essential biological molecules that the body produces deliberately and in carefully regulated quantities.

Structural roles. Cholesterol is a critical structural component of every cell membrane in the human body. It modulates membrane fluidity, allowing cells to maintain their shape and function across varying temperatures. Without adequate cholesterol, cell membranes become too rigid or too permeable, compromising cellular function. The brain is particularly cholesterol-rich, containing approximately 25% of the body's total cholesterol despite representing only about 2% of body weight. Myelin, the insulating sheath around nerve fibers that enables rapid signal transmission, is approximately 70% cholesterol by dry weight.

Vitamin D synthesis. Cholesterol is the precursor molecule for vitamin D production. When UVB radiation strikes the skin, it converts 7-dehydrocholesterol (a cholesterol derivative) into cholecalciferol (vitamin D3), which then undergoes further activation in the liver and kidneys. Without cholesterol, the body cannot manufacture vitamin D — a hormone that influences over 1,000 genes and is essential for calcium metabolism, immune function, and mood regulation.

Hormone production. Cholesterol is the parent molecule for all steroid hormones, including cortisol (the primary stress and anti-inflammatory hormone), aldosterone (which regulates blood pressure and electrolyte balance), estrogen, progesterone, and testosterone (the sex hormones that regulate reproduction, bone density, muscle mass, and mood), and DHEA (a precursor to multiple hormones). The adrenal glands and gonads actively import cholesterol from the bloodstream to fuel hormone synthesis. Aggressively lowering cholesterol can, in some individuals, impair hormone production.

Bile acid production. The liver converts cholesterol into bile acids, which are stored in the gallbladder and released into the small intestine during digestion. Bile acids are essential for the emulsification and absorption of dietary fats and fat-soluble vitamins (A, D, E, K). They also serve as signaling molecules that regulate glucose metabolism, energy expenditure, and gut microbiome composition through the farnesoid X receptor (FXR) and TGR5 receptor pathways.

Triglycerides, meanwhile, serve as the body's primary form of stored energy. They are far more calorie-dense than glycogen and can be mobilized during fasting, exercise, or periods of increased energy demand. In their proper context, triglycerides are not pathological — they are a fundamental component of energy metabolism.

"The question is not whether cholesterol is 'good' or 'bad.' The question is why the body's exquisitely regulated cholesterol metabolism has become dysregulated — and what is driving that dysregulation."

Three Myths That Continue to Mislead

Despite decades of evolving research, several myths about cholesterol persist in both popular culture and, unfortunately, in clinical practice. Addressing these myths directly is essential for practitioners who want to have honest, evidence-based conversations with their clients.

Myth 1: Dietary Cholesterol Raises Serum Cholesterol

For years, dietary guidelines warned against cholesterol-rich foods like eggs, shrimp, and organ meats, based on the assumption that eating cholesterol would directly increase blood cholesterol levels. This assumption was logical on the surface but turns out to be largely incorrect.

The body produces approximately 800-1,000 mg of cholesterol per day endogenously, primarily in the liver. Dietary cholesterol intake typically ranges from 200-500 mg per day. The body has a robust feedback mechanism: when dietary cholesterol intake increases, hepatic cholesterol synthesis decreases to compensate, and vice versa. In the majority of individuals (approximately 70-75% of the population, often called "hypo-responders"), dietary cholesterol has minimal impact on serum cholesterol levels.

The remaining 25-30% ("hyper-responders") do show increases in total cholesterol with increased dietary intake, but importantly, they tend to show proportional increases in both LDL and HDL, preserving the ratio between them — which many researchers consider more prognostically important than absolute LDL levels. The 2020 Dietary Guidelines for Americans quietly removed the previous recommendation to limit dietary cholesterol to 300 mg per day, acknowledging the evidence. Yet the myth persists.

Myth 2: Saturated Fat Is the Primary Driver of Heart Disease

The diet-heart hypothesis — the idea that saturated fat intake raises cholesterol and thereby causes heart disease — has been the cornerstone of dietary recommendations since Ancel Keys' Seven Countries Study in the 1960s. However, the evidence accumulated over subsequent decades has been far less conclusive than commonly assumed.

A 2020 meta-analysis published in the Journal of the American College of Cardiology concluded that "the recommendation to limit dietary saturated fatty acid intake has persisted despite mounting evidence to the contrary." The analysis found that while saturated fat intake does raise LDL cholesterol, it predominantly increases the large, buoyant LDL particles (pattern A) rather than the small, dense LDL particles (pattern B) that are more strongly associated with cardiovascular risk. Saturated fat also raises HDL cholesterol and improves the LDL-to-HDL ratio in many individuals.

This is not to say that saturated fat is irrelevant or that unlimited intake is advisable. Rather, it is to say that the relationship between saturated fat and heart disease is far more complex than "saturated fat raises cholesterol, which causes heart attacks." The context matters enormously: saturated fat consumed within a whole-foods diet alongside adequate fiber, micronutrients, and physical activity behaves very differently in the body than saturated fat consumed within a hyper-processed, nutrient-poor dietary pattern.

Myth 3: Low-Fat Diets Are the Best Approach to Lipid Health

If saturated fat were the primary villain, then low-fat diets should produce the best cardiovascular outcomes. But the evidence tells a different story. The Women's Health Initiative — one of the largest and longest randomized dietary intervention trials ever conducted, involving nearly 49,000 women followed for over 8 years — found that a low-fat dietary intervention did not significantly reduce the risk of coronary heart disease, stroke, or cardiovascular disease.

Low-fat diets often lead to increased consumption of refined carbohydrates and sugars, as these are used to replace the palatability lost when fat is removed from food. This substitution can worsen triglyceride levels, reduce HDL cholesterol, increase small dense LDL particles, and promote insulin resistance — all of which are risk factors for cardiovascular disease. The irony is that the low-fat dietary paradigm may have inadvertently worsened the very conditions it was designed to prevent.

The most evidence-supported dietary patterns for cardiovascular health — Mediterranean, DASH, and traditional diets from long-lived populations — are not low-fat diets. They are diets that emphasize food quality over macronutrient ratios, featuring abundant vegetables, whole grains, legumes, nuts, olive oil, and fish, with moderate amounts of saturated fat from whole-food sources.

Root Cause: It Starts with Insulin

If dietary cholesterol and saturated fat are not the primary drivers of dyslipidemia, then what is? Increasingly, the evidence points to insulin resistance as the central metabolic disturbance underlying the most common pattern of abnormal lipids seen in clinical practice.

The acetyl-CoA connection. To understand why insulin resistance drives cholesterol production, we need to follow the biochemistry. When blood glucose and insulin levels are chronically elevated — as they are in insulin resistance — the liver receives a constant flood of glucose that exceeds its energy needs. This excess glucose is metabolized through glycolysis and the citric acid cycle, generating large amounts of acetyl-CoA. Acetyl-CoA is the universal building block for both fatty acid synthesis (producing triglycerides) and cholesterol synthesis. In insulin resistance, the liver is essentially being forced to overproduce both triglycerides and cholesterol because it has more acetyl-CoA than it can use for energy.

HMG-CoA reductase upregulation. The rate-limiting enzyme in cholesterol biosynthesis is HMG-CoA reductase — the same enzyme that statin drugs inhibit. Insulin directly upregulates the activity of this enzyme through the transcription factor SREBP-2 (sterol regulatory element-binding protein 2). When insulin levels are chronically high, HMG-CoA reductase activity increases, and the liver produces more cholesterol regardless of dietary intake. This is why a patient can eat a "perfect" diet and still have elevated cholesterol — because the driver is not dietary cholesterol but insulin-mediated overproduction.

This insulin-centric model also explains the classic lipid triad of insulin resistance, known as atherogenic dyslipidemia:

  1. Elevated triglycerides — from de novo lipogenesis driven by excess acetyl-CoA
  2. Low HDL cholesterol — because increased triglyceride-rich VLDL particles exchange triglycerides for cholesterol esters with HDL particles via CETP (cholesteryl ester transfer protein), leading to triglyceride-enriched HDL that is rapidly cleared from circulation
  3. Increased small, dense LDL particles — for the same reason; VLDL-derived LDL particles become enriched with triglycerides via CETP, and when hepatic lipase cleaves those triglycerides, what remains is a smaller, denser, more atherogenic LDL particle

For practitioners, this means that addressing insulin resistance — through dietary modification, physical activity, sleep optimization, and stress management — is often the most effective upstream intervention for improving the entire lipid profile.

The Thyroid Connection

After insulin resistance, thyroid dysfunction is the most commonly overlooked root cause of elevated cholesterol. The thyroid hormones T3 and T4 have direct, well-documented effects on cholesterol metabolism, and even subclinical hypothyroidism (elevated TSH with normal T3/T4 levels) can significantly impact lipid profiles.

T3 and T4 effects on cholesterol. Active thyroid hormone (T3) upregulates LDL receptor expression on liver cells, increasing the liver's ability to clear LDL cholesterol from the bloodstream. T3 also stimulates the conversion of cholesterol to bile acids (via upregulation of CYP7A1, the rate-limiting enzyme in bile acid synthesis), providing an additional clearance pathway. When thyroid function is low, both of these mechanisms slow down: LDL receptors decrease, bile acid conversion declines, and serum cholesterol rises. Studies have shown that hypothyroid patients can have LDL cholesterol levels 30-50% higher than euthyroid individuals, and that appropriate thyroid hormone replacement often normalizes lipid levels without any dietary intervention.

Nutrient cofactors. Optimal thyroid function requires a constellation of nutrients, including iodine (the structural component of thyroid hormones), selenium (required for the deiodinase enzymes that convert T4 to active T3), zinc (necessary for thyroid hormone receptor binding), iron (required for the thyroid peroxidase enzyme), and vitamin D (which modulates thyroid autoimmunity). Deficiency in any of these nutrients can impair thyroid function and secondarily affect cholesterol metabolism. For practitioners, this means that a client presenting with elevated cholesterol should be assessed not only for overt thyroid disease but for the nutritional status of these key cofactors.

Chronic stress and the HPA-thyroid axis. Chronic psychological or physiological stress elevates cortisol, which inhibits the conversion of T4 to T3 and increases the conversion of T4 to reverse T3 (rT3, an inactive form). This is known as "euthyroid sick syndrome" or "non-thyroidal illness syndrome" — thyroid lab values may appear normal (TSH and T4 within range) while the active hormone (T3) is functionally low and rT3 is elevated. This chronic-stress pattern can contribute to cholesterol elevation that does not respond to dietary changes alone, because the root cause is neuroendocrine rather than nutritional.

HDL, LDL, and the Question of Particle Size

The conventional lipid panel measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. While useful as a screening tool, this panel has significant limitations that practitioners should understand.

Standard LDL cholesterol is typically calculated using the Friedewald equation (LDL = Total Cholesterol − HDL − Triglycerides/5), not directly measured. This calculation becomes unreliable when triglycerides are elevated (>150 mg/dL) or very low (<70 mg/dL), and it tells us nothing about the number or size distribution of LDL particles — which growing evidence suggests matters more than the total cholesterol content of those particles.

LDL particles exist on a spectrum from large and buoyant (pattern A) to small and dense (pattern B). Small, dense LDL particles are considered more atherogenic because they:

The NMR LipoProfile test (Nuclear Magnetic Resonance) directly measures LDL particle number (LDL-P) and size distribution, providing a more nuanced picture of cardiovascular risk than standard LDL-C. Two individuals can have identical LDL-C values but dramatically different risk profiles based on particle number and size. For example:

Marker Patient A Patient B
LDL-C 130 mg/dL 130 mg/dL
LDL-P (particle number) 900 nmol/L 1,800 nmol/L
LDL size Large, buoyant (pattern A) Small, dense (pattern B)
Cardiovascular risk Low Significantly elevated

For practitioners, recommending an NMR LipoProfile (or similar advanced lipid testing) can be valuable for clients with borderline or discordant standard lipid values, or for those with metabolic syndrome or insulin resistance where small dense LDL is likely the predominant pattern.

Evidence-Based Nutrition Interventions

With a root-cause understanding of what drives dyslipidemia, we can now examine the evidence for specific nutritional interventions. These are not alternatives to addressing the underlying metabolic drivers (insulin resistance, thyroid dysfunction, chronic stress) but rather complementary tools that can be layered in strategically.

Soluble Fiber

Soluble fiber — found in oats, barley, legumes, flaxseed, psyllium husk, and certain fruits and vegetables — is one of the most consistently supported interventions for LDL cholesterol reduction. The mechanism is well-established: soluble fiber binds to bile acids in the small intestine, preventing their reabsorption and forcing the liver to synthesize new bile acids from cholesterol, thereby reducing circulating cholesterol levels. Meta-analyses indicate that 5-10 grams of soluble fiber per day can reduce LDL cholesterol by 5-11%. Psyllium husk at doses of 10-12 grams per day has shown reductions of 7-10% in well-controlled trials. Soluble fiber also feeds beneficial gut bacteria, producing short-chain fatty acids that independently improve metabolic health.

Garlic and Allicin

Garlic (Allium sativum) and its bioactive sulfur compound allicin have been studied extensively for their effects on lipid metabolism. Allicin inhibits HMG-CoA reductase (the same target as statin drugs) and several other enzymes in the cholesterol biosynthetic pathway, including squalene monooxygenase. Meta-analyses of randomized controlled trials indicate that garlic supplementation (typically aged garlic extract at 600-1,200 mg/day or raw garlic equivalent) can reduce total cholesterol by 10-15 mg/dL and LDL cholesterol by 6-10 mg/dL. The effect is modest but clinically meaningful, particularly in combination with other interventions. Garlic also has anti-inflammatory, blood-pressure-lowering, and antiplatelet effects that contribute to its overall cardiovascular benefit.

Berberine

Berberine, an alkaloid found in plants such as Berberis vulgaris (barberry), Coptis chinensis (goldthread), and Hydrastis canadensis (goldenseal), has emerged as one of the most potent botanical interventions for metabolic health. Its mechanism of action on cholesterol involves upregulation of LDL receptor expression on hepatocytes (through PCSK9 inhibition, similar to the mechanism of injectable PCSK9 inhibitor drugs) and activation of AMPK (AMP-activated protein kinase), a master metabolic regulator that inhibits cholesterol and fatty acid synthesis.

Clinical trials have shown that berberine at 500 mg two to three times daily can reduce total cholesterol by 18-29%, LDL cholesterol by 20-25%, and triglycerides by 25-35%. It simultaneously improves fasting glucose and insulin sensitivity, addressing the insulin resistance that often underlies dyslipidemia. The magnitude of these effects is comparable to some statin medications, which has generated considerable interest in berberine as a naturally-derived lipid-lowering agent.

Red Yeast Rice

Red yeast rice is produced by fermenting white rice with the mold Monascus purpureus. The fermentation produces monacolin K, which is chemically identical to the active form of lovastatin, the first commercially available statin drug. Red yeast rice also contains other monacolins, sterols, and isoflavones that may contribute to its lipid-lowering effects beyond monacolin K alone. Clinical trials have demonstrated LDL cholesterol reductions of 15-25% with standardized red yeast rice extract.

However, practitioners should be aware that red yeast rice is essentially a low-dose statin, and some individuals may experience the same side effects (myalgia, elevated liver enzymes) as with prescription statins. Product quality also varies significantly, with independent testing revealing wide variation in monacolin K content and the occasional presence of the nephrotoxin citrinin. If recommending red yeast rice, quality sourcing and monitoring are essential.

Green Tea and EGCG

Green tea and its primary polyphenol, epigallocatechin gallate (EGCG), have multiple mechanisms of action relevant to cholesterol metabolism. EGCG inhibits cholesterol absorption in the intestine by interfering with the formation of cholesterol micelles and by downregulating the NPC1L1 transporter (the same transporter targeted by the drug ezetimibe). EGCG also upregulates LDL receptor expression and inhibits the oxidation of LDL particles. Meta-analyses indicate that green tea consumption or EGCG supplementation can reduce total cholesterol by 5-7 mg/dL and LDL cholesterol by 5-6 mg/dL. The effects are modest but are accompanied by antioxidant, anti-inflammatory, and metabolic benefits that extend well beyond lipid management.

Niacin (Vitamin B3) for HDL

Niacin (nicotinic acid) remains the most effective pharmacological agent for raising HDL cholesterol, with increases of 15-35% at therapeutic doses (1,500-2,000 mg/day). Niacin also reduces triglycerides (by 20-50%), LDL cholesterol (by 5-25%), and lipoprotein(a) — the only widely available agent that substantially reduces Lp(a). The mechanism involves inhibition of diacylglycerol acyltransferase 2 in the liver, reducing VLDL production, and inhibition of HDL catabolism.

However, niacin must be used with awareness of its side effects. The flushing reaction (skin redness, warmth, and itching caused by prostaglandin release) is common and can be managed with gradual dose titration and taking niacin with meals. Extended-release niacin formulations reduce flushing but may carry slightly higher hepatotoxicity risk. Niacin can also impair glucose tolerance, which is counterproductive in insulin-resistant individuals. For these reasons, niacin is best used selectively and with appropriate monitoring.

Omega-3 Fatty Acids

The omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), found in fatty fish and fish oil, are well-established interventions for elevated triglycerides. At doses of 2-4 grams/day of combined EPA+DHA, triglyceride reductions of 15-30% are consistently observed. The mechanism involves suppression of hepatic VLDL synthesis and increased VLDL clearance. EPA and DHA also have anti-inflammatory effects (reducing pro-inflammatory eicosanoids and resolvins), anti-arrhythmic properties, and endothelial function benefits that contribute to cardiovascular protection independent of their lipid effects.

The REDUCE-IT trial demonstrated that high-dose icosapent ethyl (purified EPA at 4 g/day) reduced major cardiovascular events by 25% in statin-treated patients with elevated triglycerides, suggesting that the cardiovascular benefits of omega-3s extend beyond triglyceride lowering.

Lifestyle Factors: The Non-Negotiables

No supplement protocol can substitute for the foundational lifestyle factors that regulate cholesterol metabolism. These are non-negotiable components of any comprehensive approach.

Exercise. Regular physical activity improves insulin sensitivity (reducing the insulin-driven overproduction of cholesterol), increases HDL cholesterol, shifts LDL particle distribution toward larger, more buoyant particles, and reduces triglycerides. Both aerobic exercise and resistance training have demonstrated lipid benefits. The American Heart Association recommends at least 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity aerobic activity per week, but evidence suggests that more is better, with dose-response relationships observed up to significantly higher activity levels.

Sleep. Sleep deprivation and poor sleep quality are independently associated with dyslipidemia, insulin resistance, and cardiovascular risk. Studies have shown that restricting sleep to 5-6 hours per night for even one week increases insulin resistance, raises cortisol, and adversely affects lipid profiles. Prioritizing 7-9 hours of quality sleep is a foundational intervention for metabolic health.

Stress management. Chronic psychological stress elevates cortisol, which increases hepatic gluconeogenesis, promotes insulin resistance, inhibits T4-to-T3 conversion, and directly upregulates HMG-CoA reductase activity. Through these mechanisms, unmanaged chronic stress can drive dyslipidemia even in the presence of an otherwise optimal diet. Evidence-based stress management practices include regular physical activity, mindfulness meditation, adequate social connection, time in nature, and cognitive behavioral approaches.

Environmental toxin reduction. Emerging evidence links environmental toxin exposure — particularly persistent organic pollutants (POPs), heavy metals, and endocrine-disrupting chemicals — to dyslipidemia and cardiovascular risk. These toxins can impair thyroid function, promote insulin resistance, increase oxidative stress, and directly interfere with lipid metabolism. While complete avoidance is impossible in the modern environment, practitioners can help clients reduce exposure through dietary choices (organic produce, filtered water, reduced plastic use), household modifications (air filtration, non-toxic cleaning products), and supporting the body's detoxification pathways through adequate nutrition.

A Note on Statins and CoQ10

This article is not anti-statin. Statin medications have a well-established evidence base for reducing cardiovascular events in specific populations, particularly those with established cardiovascular disease (secondary prevention) and those at high cardiovascular risk. The decision to use or not use statins is a medical decision between a patient and their physician, informed by individual risk assessment, and it is outside the scope of practice for most nutrition practitioners.

However, practitioners should be aware that statins inhibit HMG-CoA reductase — the same enzyme that produces coenzyme Q10 (CoQ10), also known as ubiquinone. CoQ10 is essential for mitochondrial energy production and serves as a potent intracellular antioxidant. Statin use has been shown to reduce circulating CoQ10 levels by 16-40%, and CoQ10 depletion has been implicated in statin-associated muscle symptoms (myalgia, weakness, fatigue), which affect an estimated 10-25% of statin users.

Supplementation with CoQ10 at 100-200 mg/day (in the ubiquinol form for better absorption) has been shown in multiple studies to reduce the severity of statin-associated myalgia and improve quality of life in statin users. For clients who are taking statins, recommending CoQ10 supplementation is a straightforward, evidence-supported intervention that can improve tolerability and address a genuine nutrient depletion.

Closing: Systems Thinking for Lipid Health

The conventional approach to cholesterol management — measure LDL, prescribe a statin if it is high, advise a low-fat diet — is a reductive model that misses the complexity of human metabolism. It treats a lab number as the disease rather than asking what is driving that number.

A holistic, functional approach asks different questions. Is there insulin resistance driving hepatic cholesterol overproduction? Is thyroid function optimal, including T4-to-T3 conversion? What is the particle size distribution — is the LDL actually atherogenic? Are there nutritional deficiencies impairing the metabolic pathways that regulate lipid metabolism? What lifestyle factors — sleep, stress, movement, environmental exposures — are contributing?

When practitioners learn to think this way, cholesterol becomes not a problem to be suppressed but a signal to be interpreted. Elevated cholesterol is the body communicating that something in its metabolic environment needs attention. Our job is to listen, investigate, and address the root cause — not to silence the messenger.

"Cholesterol is not the enemy. It is a molecule with a story to tell. The practitioner's role is to learn the language in which that story is written."

The evidence-based interventions outlined in this article — from soluble fiber and berberine to sleep optimization and stress management — provide a comprehensive toolkit for practitioners working at the intersection of functional nutrition and cardiovascular health. Used thoughtfully, in combination with appropriate medical oversight and advanced lipid testing, they represent a systems-level approach to lipid health that honors the complexity of the human body.